Integer Holdings (WGB) Stock Overview
Operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
WGB Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Integer Holdings Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$75.50 |
| 52 Week High | US$111.00 |
| 52 Week Low | US$54.00 |
| Beta | 0.71 |
| 1 Month Change | 6.34% |
| 3 Month Change | 4.86% |
| 1 Year Change | -25.98% |
| 3 Year Change | 2.72% |
| 5 Year Change | -3.21% |
| Change since IPO | 206.91% |
Recent News & Updates
Recent updates
Shareholder Returns
| WGB | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 5.6% | 2.0% | 2.7% |
| 1Y | -26.0% | -16.2% | 10.2% |
Return vs Industry: WGB underperformed the German Medical Equipment industry which returned -14.9% over the past year.
Return vs Market: WGB underperformed the German Market which returned 11.2% over the past year.
Price Volatility
| WGB volatility | |
|---|---|
| WGB Average Weekly Movement | 3.8% |
| Medical Equipment Industry Average Movement | 6.1% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in DE Market | 13.7% |
| 10% least volatile stocks in DE Market | 2.6% |
Stable Share Price: WGB has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: WGB's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1970 | 11,000 | Payman Khales | www.integer.net |
Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; implanted medical devices, implanted leads, procedure accessories, and external devices; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies.
Integer Holdings Corporation Fundamentals Summary
| WGB fundamental statistics | |
|---|---|
| Market cap | €2.61b |
| Earnings (TTM) | €87.24m |
| Revenue (TTM) | €1.57b |
Is WGB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| WGB income statement (TTM) | |
|---|---|
| Revenue | US$1.85b |
| Cost of Revenue | US$1.35b |
| Gross Profit | US$507.71m |
| Other Expenses | US$404.88m |
| Earnings | US$102.83m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
Apr 30, 2026
| Earnings per share (EPS) | 3.02 |
| Gross Margin | 27.39% |
| Net Profit Margin | 5.55% |
| Debt/Equity Ratio | 68.2% |
How did WGB perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/20 12:31 |
| End of Day Share Price | 2026/04/20 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Integer Holdings Corporation is covered by 17 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jasper Hellweg | Argus Research Company |
| Robert Wasserman | Benchmark Company |
| Travis Steed | BofA Global Research |